1068. Phenotypic and Genotypic Characterization of Staphylococcus aureus Bloodstream Isolates in a Single Large Medical Center in Southeastern Minnesota
Session: Poster Abstract Session: Clinical Infectious Diseases: Bacteremia and Endocarditis
Friday, October 28, 2016
Room: Poster Hall

Staphylococcus aureus is a leading cause of bacteremia often associated with high levels of morbidity and mortality. It is well known that S. aureus can produce superantigens as virulence factors, but it is unclear what role superantigens play in S. aureusbacteremia (SAB). The epidemiology of SAB varies by region. We investigated the clinical and molecular epidemiology of SAB isolates and the prevalence of their superantigen production.


154 SAB isolates collected throughout 2015 were studied; clinical data were analyzed. Molecular typing was performed using Staphylococcus protein A (spa) typing. Superantigen genes sea, seb, sec, sed, see, seg, seh, sei, sej, and tst were detected by PCR. Mitogenic activities of superantigens were assayed using splenocytes from HLA-DR3 transgenic mice stimulated by supernatants of planktonic cultures of the isolates.


106 isolates (69%) were methicillin–susceptible S. aureus (MSSA). When MSSA and methicillin resistant S. aureus (MRSA) were compared, there were no differences in age, gender, underlying illness, primary site of infection, severity of infection, superantigen production, or mortality. More than 50% of MRSA isolates and 13% of MSSA isolates were resistant to clindamycin. Less than 3% of MRSA isolates were resistant to rifampin, mupirocin, or trimethoprim-sulfamethoxazole. spa typing showed 82 spa types clustered into 11 spa clonal complexes (CCs). Typing of MSSA revealed a wide genotypic diversity. Of the 48 MRSA isolates, 42 (88%) belonged to spa CC-002 and CC-008. The sej gene was the most prevalent, found in 122 S. aureus isolates (79%) and more than 50% of isolates had tst, sec, seg, and sei genes. Superantigen genes were equally distributed between MSSA and MRSA. The number of deaths attributed to SAB, deaths not attributed to SAB, and 30-day survival were 24 (16%), 2 (1%), and 128 (83%), respectively. Superantigens were not related with mortality.


The predominant strain was MSSA. Most MRSA isolates belonged to spa CC-002 and CC-008. Superantigen genes were prevalent in SAB and many isolates produced functional superantigens; however, superantigens were not related with mortality.

Kyung-Hwa Park, MD, Internal Medicine, Chonnam National University Hospital, Gwangju, Korea, The Republic of; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, Kerryl Greenwood-Quaintance, MS, Division of Clinical Microbiology, Mayo Clinic, Rochester, MN, Suzannah Schmidt, MS, Mayo clinic, Rochester, MN, James Uhl, MS, Mayo Clinic College of Medicine, Rochester, MN, Scott Cunningham, MT(ASCP), MS, Division of Clinical Microbiology, Dept. of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, Govindarajan Rajagopalan, Ph.D., Department of Immunology, Mayo Clinic, Rochester, MN and Robin Patel, MD, FIDSA, D(ABMM), Divisions of Clinical Microbiology and Infectious Diseases, Mayo Clinic, Rochester, MN


K. H. Park, None

K. Greenwood-Quaintance, None

S. Schmidt, None

J. Uhl, None

S. Cunningham, TIBMolBio: PCR Oligonucleotide Manufacturer , Licensing agreement or royalty

G. Rajagopalan, None

R. Patel, USMLE: Question writer , Honorarium
Up-to-Date: Writer , Honorarium
Infectious Diseases Board Review Course: Speaker , Honorarium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.